Multicenter Study of Patients With Hypertension Resistant to Patient Identification and Standardization of Therapeutic
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Clonidine (Primary) ; Spironolactone (Primary) ; ACE inhibitors; Amlodipine; Angiotensin receptor antagonists; Chlortalidone
- Indications Resistant hypertension
- Focus Biomarker; Therapeutic Use
- Acronyms ReHOT
- 07 Jun 2013 Biomarkers information updated
- 06 Jun 2013 Planned End Date changed from 1 Dec 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 03 Aug 2012 Trial phase changed from III to IV as reported by ClinicalTrials.gov.